An analytical Study to Evaluate the correlation between Serum Uric Acid Levels and Deaths in Acute Myocardial Infarction Patients At a Tertiary Level Institute Catering to Rural Population of Western Maharashtra
DOI:
https://doi.org/10.46858/vimshsj.8302Keywords:
Serum Uric Acid, Acute Myocardial Infarction, Killip‘s class, STEMI, NSTEMIAbstract
Introduction: Cardiovascular diseases are the number one cause of mortality all over the world. Elevated serum uric acid is highly predictive of mortality in patients with heart failure or coronary artery disease. We conducted this study to assess serum uric acid levels on admission as a potential predictor of short-term mortality (7 days) in acute myocardial infarction patients. Methodology: Total of 200 patients diagnosed with the myocardial infarction (MI) in our hospital along with 200 age and gender matched controls were selected for this study. The clinical history, examination, ECG changes and biochemical markers were evaluated on day 0, 3 and 7. Association with Killips class and mortality in STEMI / NSTEMI cases was done. Results: The study had 200 cases and 200 controls. The mean age of cases was 62.54 ± 18.24 years and controls was 61.94±17.25 years. There were majority males among both cases 114 (57%) and controls 112 (56%). The patients were classified using Killip’s class. Majority belong to class I 98 (49%) followed by II 42 (21%). There were 26 (13%) of class III and 34 (17%) into class IV. There is significant difference seen between uric acid levels of cases and control on day 1, 3 and 7 (p<0.001). There was 25% mortality (50 deaths) seen among the cases. There was association seen between Killips class III & IV and mortality, there was higher mortality seen in STEMI as compared to NSTEMI (i.e. p<0.05). Conclusion: Our study concludes that the serum uric acid (SUA) levels have significant association with Killip‘s class and mortality in Acute Myocardial Infarction cases.
Downloads
References
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. Journal of the American College of Cardiology. 2020 Dec 22;76(25):2982-3021.
Prabhakaran D, Jeemon P, Sharma M, Roth GA, Johnson C, Harikrishnan S, Gupta R, Pandian JD, Naik N, Roy A, Dhaliwal RS. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. The Lancet Global Health. 2018 Dec 1;6(12):e1339-51.
Chaulin AM, Duplyakov DV. Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 1. Journal of Clinical Practice. 2020 Oct 23;11(3):75-84.
Aydin S, Ugur K, Aydin S, Sahin ?, Yardim M. Biomarkers in acute myocardial infarction: current perspectives. Vascular health and risk management. 2019;15:1.
Demiray A, Afsar B, Covic A, Kuwabara M, Ferro CJ, Lanaspa MA, Johnson RJ, Kanbay M. The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative Review. Angiology. 2021 Apr 27:00033197211012546.
Wannamethee SG, Papacosta O, Lennon L, Whincup PH. Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study. International journal of cardiology. 2018 Feb 1;252:187-92.
Li L, Ma Y, Shang XM, Hong Y, Wang JH, Tan Z, Wang YJ, Geng XB. Hyperuricemia is associated with short-term outcomes in elderly patients with acute myocardial infarction. Aging clinical and experimental research. 2018 Oct;30(10):1211-5.
Baruah M. C-Reactive Protein (CRP) and Markers of Oxidative Stress in Acute Myocardial Infarction. InClinical Significance of C-reactive Protein 2020 (pp. 95-115). Springer, Singapore.
Yasa H. Prognosis and Complications of Hyper-uricemia Patients Undergoing Isolated Coronary Artery Bypass Surgery. J Cardiothorac Surg Ther. 2020;4(1):61-0.
Harada-Shiba M, Ako J, Arai H, Hirayama A, Murakami Y, Nohara A, Ozaki A, Uno K, Nakamura M. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study. Atherosclerosis. 2018 Oct 1;277:362-8.
Fukutomi M, Nishihira K, Honda S, Kojima S, Takegami M, Takahashi J, Itoh T, Watanabe T, Takenaka T, Ito M, Takayama M. Difference in the in-hospital prognosis between ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction with high Killip class: Data from the Japan Acute Myocardial Infarction Registry. European Heart Journal Acute Cardiovascular Care. 2021 May;10(5):503-12.
Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Nuevo J, Guallar E, Perk J, Banegas JR, Tubach F, Roy C. Serum uric acid levels are associated with cardiovascular risk score: a post hoc analysis of the EURIKA study. International journal of cardiology. 2018 Feb 15;253:167-73.
Watanabe S, Usui M. Serum uric acid level is associated with reperfusion ventricular arrhythmias in acute myocardial infarction. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021 Jul 1;15(4):102198.
Kumar N, Kumar H, Kumar V, Nayyer PS. A Study of the Serum Uric Acid Level as Prognostic Indicator in Acute Myocardial Infarction. The Journal of the Association of Physicians of India. 2020 Feb 1;68(2):31-4.
Nadkar MY, Jain VI. Serum uric acid in acute myocardial infarction. The Journal of the Association of Physicians of India. 2008 Oct;56:759-762.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Dr. Jalindar Baravkar, Dr. Shivnath Parkhe, Dr. Satish M. Kopurwad, Dr. Amrut A. Swami
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.